Burst Biologics Home

Rethinking & Evolving Science


As a science-driven company that focuses on science-driven technologies, Burst Biologics is committed to providing state of the art cellular and a-cellular allografts. Every product that we process is carefully analyzed in our federally registered tissue bank. Burst Biologics does not release tissue from our laboratory unless it meets our rigorous release criteria. From donor collection to final package, Burst Biologics sets the standard for the future in spine biologics and regenerative medicine. Subscribe to our blog to learn more about the latest developments in biologic technology.


Read More



The patent pending Progenokine processing technique incorporates unique breakthroughs in cryoprotection exclusive to Burst Biologics. Developed under stringent standards, the Progenokine Process goes above and beyond the industry standard. This ensures verifiable conformance and efficiency for practitioners, and safety for patients.